Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET

Figure 4

MAMMI maximum intensity projections (MIPs) showing assessment of tumor metabolic response to neoadjuvant chemotherapy in a patient with multifocal breast cancer (a) and disappearance of FDG uptake in the breast lesions (b). The same pattern of complete metabolic response is seen for another patient with two breast tumors (c and d). By contrast, no significant response is seen in a patient with a T2 tumor (e and f) and in another patient with a T1-invasive breast carcinoma (g and h).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)